Summary

The global Cosmetic Functional Ingredients market is projected to grow from US$ 3551 million in 2025 to US$ 5458 million by 2032, at a CAGR of 6.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Cosmetic Functional Ingredients refer to specialty active or efficacy-oriented ingredients incorporated into facial skin care, body care, hair and scalp care, sun and after-sun care, and functional color cosmetic formulations primarily to deliver defined cosmetic benefits. These ingredients directly influence the condition, structure or appearance of the skin, scalp or hair and are specifically developed or marketed for benefits such as moisturization, barrier repair, soothing, anti-aging and wrinkle reduction, firming, brightening and complexion improvement, antioxidant and environmental protection, sebum and blemish control, and hair and scalp improvement. Major product groups include botanical actives, peptides and proteins, polysaccharides, lipids and ceramides, vitamins and their derivatives, amino acids, osmolytes and other specialty bioactive molecules. In this report, Cosmetic Functional Ingredients are limited to specialty ingredients whose principal commercial purpose is to provide a defined cosmetic efficacy or care benefit. Ingredients used primarily for basic formulation or processing functions, including surfactants, emulsifiers, thickeners, rheology modifiers, solubilizers, solvents, preservatives, colorants and fragrances, are excluded. Stand-alone specialty categories such as UV filters and antiperspirant actives, as well as biomaterials primarily intended for pharmaceutical, injectable or medical-device applications, are also excluded.
Key Findings
Global demand is estimated at approximately 39,000–40,000 metric tons in 2025
The global weighted average selling price is estimated at approximately US$90 per kg in 2025
Asia-Pacific accounts for roughly 38–40% of global demand and represents the largest regional market
Botanical actives remain the largest product group while peptides and biotechnology-derived actives are expanding faster
Facial skin care represents about 60% of demand led by anti-aging moisturizing barrier-repair and brightening products
Market Trends
The industry is moving from conventional extracts and broadly positioned moisturizers toward science-backed, mechanism-specific and increasingly biotechnology-derived actives. Skin longevity, cellular repair, neurocosmetics, microbiome-related claims, barrier biology and hair/scalp health are becoming major innovation themes. Croda reported 6% constant-currency growth in Beauty Actives in 2025, while sales of its biotech-derived ceramides increased 36%, demonstrating increasing commercialization of higher-value barrier actives. LipoTrue introduced an AI-designed peptide targeting cellular longevity in 2025, while Givaudan has extended active innovation into intracellular hyaluronic acid, neuro-ageing and microbiome-linked ageing pathways. At the same time, botanical innovation is shifting from conventional extracts toward standardized fractions, upcycled biomass, plant cell culture and biofactory technologies, while fermentation and biocatalysis are improving reproducibility and scalability. Hybridization between skin care and color cosmetics is also opening incremental demand, with actives increasingly designed specifically for make-up matrices without compromising pigment stability or sensory performance. Givaudan's active botanical powders for hybrid make-up illustrate this transition.
Market Dynamics
Drivers
Demand is being driven by greater consumer focus on visible efficacy, ingredient transparency and differentiated claims, together with premiumization in skin care and rapid product renewal by local and global beauty brands. The increasing use of serums, targeted treatments, scalp essences and high-efficacy formulations raises the economic value of active ingredients relative to conventional formulation materials. Brand owners are also increasingly seeking ingredients supported by standardized composition, mechanism-of-action data and human efficacy testing because claim substantiation has become an important part of product differentiation. In China, the expansion of the new cosmetic ingredient registration and filing framework is supporting domestic ingredient innovation; by October 2025, 327 new cosmetic ingredients had been registered or filed, while subsequent regulatory reforms further emphasized ingredient innovation and pre-filing consultation.
Restraints
The principal constraint is the relatively long and costly path from discovery to commercial adoption. A differentiated active typically requires raw-material characterization, process standardization, toxicological assessment, stability evaluation, formulation compatibility studies and efficacy substantiation before broad customer adoption. Natural extracts face additional variability from crop origin, harvest conditions and bioactive composition, while fermentation-derived and peptide ingredients require tighter control of purity, contaminants and batch consistency. Customer qualification cycles can be lengthy because a new active must often be tested across different formulation systems and claim protocols. Market demand is also sensitive to beauty brand launches and discretionary consumer spending; JAKA Biotech specifically identifies downstream cosmetics demand, competitive intensity and raw-material price volatility as operating risks for cosmetic active ingredient manufacturers.
Opportunities
The largest opportunity lies in high-value actives that combine new biological targets with scalable manufacturing and strong efficacy substantiation. Peptides, ceramides, bioactive polysaccharides, fermentation-derived small molecules, plant-cell actives and precision botanical fractions are well positioned as brands seek more defensible claims. Hair and scalp care is another attractive expansion area as anti-hair-loss, scalp barrier, sebum, dandruff, microbiome and healthy-aging concepts move closer to facial-skin-care innovation. Hybrid make-up provides an additional route for active suppliers to enter color cosmetics. China offers particularly strong opportunities for domestic manufacturers with proprietary technology and regulatory capabilities: JAKA Biotech's filing identifies its core business as R&D, production and sale of cosmetic efficacy ingredients, while the China Association of Fragrance Flavor and Cosmetic Industries identified it among the top five participants in China's cosmetic functional ingredient market in 2025.
Challenges
The industry faces growing pressure to prove that increasingly sophisticated biological claims can translate into reproducible consumer benefits at realistic use concentrations. Competition is moving beyond ingredient discovery toward data quality, intellectual property, delivery technology, regulatory dossiers and global application support. At the same time, the market lacks a completely standardized unit-price structure because products can be sold as high-purity powders, standardized extracts or diluted active preparations in water, glycerin or other carriers. Market accounting therefore requires consistent treatment of commercial as-sold formulations to avoid overstating or understating volume and ASP. Another challenge is rapid concept replication: attractive claims such as longevity, neurocosmetics and microbiome support can quickly attract competing ingredients, shortening differentiation windows and increasing the importance of patents, proprietary processes, clinical data and exclusive sourcing.
Industry Chain Analysis
The upstream industry includes botanical and marine biomass, fermentation substrates, sugars, amino acids, lipids, specialty intermediates, enzymes, microbial strains and other biological resources. Midstream manufacturers create most of the value through extraction and fractionation, fermentation, cell culture, bioconversion, peptide synthesis, specialty synthesis, purification and formulation, followed by standardization, analytical characterization, safety assessment and efficacy testing. Some manufacturers also develop delivery systems and provide formulation prototypes, regulatory documentation and application support. The downstream market consists primarily of global and regional cosmetic groups, independent beauty brands, OEM/ODM manufacturers and specialist formulators. Professional sourcing is structurally important because beauty companies often purchase technically mature raw materials from specialist ingredient manufacturers rather than vertically integrating upstream production, while customized development is increasingly used to create differentiated claims. Value creation is therefore concentrated not only in manufacturing yield but also in proprietary biology, reproducible quality, claim substantiation and the ability to accelerate customer formulation and launch cycles.
Segment Insights
By ingredient type, Botanical Actives remain the largest segment and are estimated to contribute roughly one-third of market revenue, supported by broad use in moisturizing, soothing, brightening, antioxidant and anti-aging formulations. Peptides & Proteins represent a smaller but higher-value segment and are among the fastest-growing categories because of strong positioning in wrinkle reduction, firmness, extracellular-matrix support and longevity concepts. Polysaccharides are anchored by hyaluronic-acid derivatives, beta-glucans and other fermentation or botanical glycans, while Lipids & Ceramides are gaining importance in barrier repair and scalp health. Croda's rapid growth in ceramide sales following the Solus Biotech acquisition illustrates increasing commercial adoption of this category. By origin, plant-derived ingredients continue to account for the largest share, while fermentation-derived actives are gaining share because biotechnology offers better standardization, supply scalability and access to molecules that are difficult to obtain efficiently from conventional extraction.
Downstream Market Opportunities
Facial skin care is estimated to represent around 60% of total demand and remains the principal commercialization platform for anti-aging, brightening, barrier repair, hydration, sensitive-skin and longevity actives. Hair & Scalp Care is the second most attractive application because scalp serums and treatment-oriented hair products increasingly use technologies previously concentrated in facial care, including peptides, ceramides, microbiome-related ingredients and botanical actives. Body Care provides stable demand for moisturizing, barrier, firming and tone-improvement ingredients, while Sun & After-Sun Care creates demand for antioxidants, soothing and repair actives rather than UV filters themselves. Color Cosmetics remains smaller but offers above-average innovation potential as foundation, primers and other hybrid products incorporate measurable skin benefits; Givaudan's development of active botanical powders specifically designed for make-up demonstrates the commercial relevance of this crossover.
Regional Insights
Asia-Pacific is estimated to account for approximately 38–40% of global demand, making it the largest regional market. China, Japan and South Korea combine large skin-care consumption with increasingly sophisticated domestic ingredient development, while regional beauty brands are shortening innovation cycles and adopting locally differentiated botanicals, fermentation products, peptides and scalp-care actives. Croda reported a 16% increase in Beauty Actives sales in Asia excluding acquired ceramides, including double-digit growth in China, highlighting the importance of local and regional beauty customers. China is also becoming increasingly important as an upstream innovation base as regulatory pathways for new cosmetic ingredients mature. Europe remains a major innovation and production center, supported by leading active-ingredient specialists in France, Germany, Switzerland and Spain, while North America is characterized by high-value clinical positioning, independent beauty brands and strong demand for biotech and natural active concepts.
Competitive Landscape Analysis
Competition is fragmented but increasingly structured around large global ingredient platforms and specialized active-ingredient companies. Croda, Givaudan, Symrise, dsm-firmenich, BASF and Clariant combine global sales networks, formulation support and broad R&D capabilities, while Seppic, SILAB, Solabia, Greentech, Gattefossé, LipoTrue, CLR Berlin and other specialists compete through deeper expertise in botanicals, peptides, fermentation and proprietary efficacy concepts. M&A is accelerating portfolio consolidation: Clariant completed its USD810 million acquisition of Lucas Meyer Cosmetics from IFF in 2024; Croda acquired South Korea-based Solus Biotech to add biotech-derived ceramides and phospholipids; Syensqo acquired JinYoung Bio and subsequently launched its Cerafy biomimetic ceramide platform; and Solabia completed the acquisition of Mibelle Biochemistry in 2026, adding plant-cell and biotechnology capabilities. Chinese suppliers such as Bloomage Biotech, JAKA Biotech, Freda Biotechnology, Winkey Technology, Spec-Chem Industry and SIYOMICRO are strengthening competition through fermentation, peptides, polysaccharides, botanical extraction and synthetic biology, creating a market in which scientific differentiation and application data increasingly matter as much as production scale.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Cosmetic Functional Ingredients market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Croda
Givaudan
Symrise
dsm-firmenich
BASF
Clariant
Solabia
Evonik
Seppic
Ashland
SILAB
Lubrizol
Ichimaru Pharcos
Greentech
Gattefossé
Provital
LipoTrue
IFF
Syensqo
CLR Berlin
Active Concepts
Expanscience
Lipoid Kosmetik
Vytrus Biotech
Bloomage Biotech
JAKA Biotech
Shandong Freda Biotechnology
Winkey Technology
Spec-Chem Industry
SIYOMICRO
DX Chemical
Segment by Type
Botanical Actives
Peptides & Proteins
Polysaccharides
Lipids & Ceramides
Others
Segment by Ingredient Origin
Plant-Derived
Marine-Derived
Fermentation-Derived
Others
Segment by Application
Facial Skin Care
Hair & Scalp Care
Body Care
Sun & After-Sun Care
Others
Segment by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Cosmetic Functional Ingredients study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Cosmetic Functional Ingredients: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Cosmetic Functional Ingredients Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Botanical Actives
1.2.3 Peptides & Proteins
1.2.4 Polysaccharides
1.2.5 Lipids & Ceramides
1.2.6 Others
1.3 Market Segmentation by Ingredient Origin
1.3.1 Global Cosmetic Functional Ingredients Market Size by Ingredient Origin, 2021 vs 2025 vs 2032
1.3.2 Plant-Derived
1.3.3 Marine-Derived
1.3.4 Fermentation-Derived
1.3.5 Others
1.4 Market Segmentation by Application
1.4.1 Global Cosmetic Functional Ingredients Market Size by Application, 2021 vs 2025 vs 2032
1.4.2 Facial Skin Care
1.4.3 Hair & Scalp Care
1.4.4 Body Care
1.4.5 Sun & After-Sun Care
1.4.6 Others
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cosmetic Functional Ingredients Revenue Estimates and Forecasts (2021-2032)
2.2 Global Cosmetic Functional Ingredients Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competitive Landscape
3.1 Global Cosmetic Functional Ingredients Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global Cosmetic Functional Ingredients Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Botanical Actives: Market Share by Key Players
3.3.2 Peptides & Proteins: Market Share by Key Players
3.3.3 Polysaccharides: Market Share by Key Players
3.3.4 Lipids & Ceramides: Market Share by Key Players
3.3.5 Others: Market Share by Key Players
3.4 Global Cosmetic Functional Ingredients Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Product Segmentation
4.1 Global Cosmetic Functional Ingredients Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Global Cosmetic Functional Ingredients Market by Ingredient Origin
4.2.1 Global Revenue by Ingredient Origin (2021-2032)
4.2.2 Global Revenue-Based Market Share by Ingredient Origin (2021-2032)
4.3 Key Product Attributes and Differentiation
4.4 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.4.1 High-Growth Niches and Adoption Drivers
4.4.2 Profitability Hotspots and Cost Drivers
4.4.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Cosmetic Functional Ingredients Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America Cosmetic Functional Ingredients Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Cosmetic Functional Ingredients Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico
7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe Cosmetic Functional Ingredients Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Cosmetic Functional Ingredients Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific Cosmetic Functional Ingredients Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific Cosmetic Functional Ingredients Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America Cosmetic Functional Ingredients Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Cosmetic Functional Ingredients Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa Cosmetic Functional Ingredients Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Cosmetic Functional Ingredients Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Croda
11.1.1 Croda Corporation Information
11.1.2 Croda Business Overview
11.1.3 Croda Cosmetic Functional Ingredients Product Features and Attributes
11.1.4 Croda Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.1.5 Croda Cosmetic Functional Ingredients Revenue by Product in 2025
11.1.6 Croda Cosmetic Functional Ingredients Revenue by Application in 2025
11.1.7 Croda Cosmetic Functional Ingredients Revenue by Geographic Area in 2025
11.1.8 Croda Cosmetic Functional Ingredients SWOT Analysis
11.1.9 Croda Recent Developments
11.2 Givaudan
11.2.1 Givaudan Corporation Information
11.2.2 Givaudan Business Overview
11.2.3 Givaudan Cosmetic Functional Ingredients Product Features and Attributes
11.2.4 Givaudan Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.2.5 Givaudan Cosmetic Functional Ingredients Revenue by Product in 2025
11.2.6 Givaudan Cosmetic Functional Ingredients Revenue by Application in 2025
11.2.7 Givaudan Cosmetic Functional Ingredients Revenue by Geographic Area in 2025
11.2.8 Givaudan Cosmetic Functional Ingredients SWOT Analysis
11.2.9 Givaudan Recent Developments
11.3 Symrise
11.3.1 Symrise Corporation Information
11.3.2 Symrise Business Overview
11.3.3 Symrise Cosmetic Functional Ingredients Product Features and Attributes
11.3.4 Symrise Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.3.5 Symrise Cosmetic Functional Ingredients Revenue by Product in 2025
11.3.6 Symrise Cosmetic Functional Ingredients Revenue by Application in 2025
11.3.7 Symrise Cosmetic Functional Ingredients Revenue by Geographic Area in 2025
11.3.8 Symrise Cosmetic Functional Ingredients SWOT Analysis
11.3.9 Symrise Recent Developments
11.4 dsm-firmenich
11.4.1 dsm-firmenich Corporation Information
11.4.2 dsm-firmenich Business Overview
11.4.3 dsm-firmenich Cosmetic Functional Ingredients Product Features and Attributes
11.4.4 dsm-firmenich Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.4.5 dsm-firmenich Cosmetic Functional Ingredients Revenue by Product in 2025
11.4.6 dsm-firmenich Cosmetic Functional Ingredients Revenue by Application in 2025
11.4.7 dsm-firmenich Cosmetic Functional Ingredients Revenue by Geographic Area in 2025
11.4.8 dsm-firmenich Cosmetic Functional Ingredients SWOT Analysis
11.4.9 dsm-firmenich Recent Developments
11.5 BASF
11.5.1 BASF Corporation Information
11.5.2 BASF Business Overview
11.5.3 BASF Cosmetic Functional Ingredients Product Features and Attributes
11.5.4 BASF Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.5.5 BASF Cosmetic Functional Ingredients Revenue by Product in 2025
11.5.6 BASF Cosmetic Functional Ingredients Revenue by Application in 2025
11.5.7 BASF Cosmetic Functional Ingredients Revenue by Geographic Area in 2025
11.5.8 BASF Cosmetic Functional Ingredients SWOT Analysis
11.5.9 BASF Recent Developments
11.6 Clariant
11.6.1 Clariant Corporation Information
11.6.2 Clariant Business Overview
11.6.3 Clariant Cosmetic Functional Ingredients Product Features and Attributes
11.6.4 Clariant Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.6.5 Clariant Recent Developments
11.7 Solabia
11.7.1 Solabia Corporation Information
11.7.2 Solabia Business Overview
11.7.3 Solabia Cosmetic Functional Ingredients Product Features and Attributes
11.7.4 Solabia Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.7.5 Solabia Recent Developments
11.8 Evonik
11.8.1 Evonik Corporation Information
11.8.2 Evonik Business Overview
11.8.3 Evonik Cosmetic Functional Ingredients Product Features and Attributes
11.8.4 Evonik Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.8.5 Evonik Recent Developments
11.9 Seppic
11.9.1 Seppic Corporation Information
11.9.2 Seppic Business Overview
11.9.3 Seppic Cosmetic Functional Ingredients Product Features and Attributes
11.9.4 Seppic Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.9.5 Seppic Recent Developments
11.10 Ashland
11.10.1 Ashland Corporation Information
11.10.2 Ashland Business Overview
11.10.3 Ashland Cosmetic Functional Ingredients Product Features and Attributes
11.10.4 Ashland Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
11.11 SILAB
11.11.1 SILAB Corporation Information
11.11.2 SILAB Business Overview
11.11.3 SILAB Cosmetic Functional Ingredients Product Features and Attributes
11.11.4 SILAB Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.11.5 SILAB Recent Developments
11.12 Lubrizol
11.12.1 Lubrizol Corporation Information
11.12.2 Lubrizol Business Overview
11.12.3 Lubrizol Cosmetic Functional Ingredients Product Features and Attributes
11.12.4 Lubrizol Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.12.5 Lubrizol Recent Developments
11.13 Ichimaru Pharcos
11.13.1 Ichimaru Pharcos Corporation Information
11.13.2 Ichimaru Pharcos Business Overview
11.13.3 Ichimaru Pharcos Cosmetic Functional Ingredients Product Features and Attributes
11.13.4 Ichimaru Pharcos Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.13.5 Ichimaru Pharcos Recent Developments
11.14 Greentech
11.14.1 Greentech Corporation Information
11.14.2 Greentech Business Overview
11.14.3 Greentech Cosmetic Functional Ingredients Product Features and Attributes
11.14.4 Greentech Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.14.5 Greentech Recent Developments
11.15 Gattefossé
11.15.1 Gattefossé Corporation Information
11.15.2 Gattefossé Business Overview
11.15.3 Gattefossé Cosmetic Functional Ingredients Product Features and Attributes
11.15.4 Gattefossé Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.15.5 Gattefossé Recent Developments
11.16 Provital
11.16.1 Provital Corporation Information
11.16.2 Provital Business Overview
11.16.3 Provital Cosmetic Functional Ingredients Product Features and Attributes
11.16.4 Provital Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.16.5 Provital Recent Developments
11.17 LipoTrue
11.17.1 LipoTrue Corporation Information
11.17.2 LipoTrue Business Overview
11.17.3 LipoTrue Cosmetic Functional Ingredients Product Features and Attributes
11.17.4 LipoTrue Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.17.5 LipoTrue Recent Developments
11.18 IFF
11.18.1 IFF Corporation Information
11.18.2 IFF Business Overview
11.18.3 IFF Cosmetic Functional Ingredients Product Features and Attributes
11.18.4 IFF Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.18.5 IFF Recent Developments
11.19 Syensqo
11.19.1 Syensqo Corporation Information
11.19.2 Syensqo Business Overview
11.19.3 Syensqo Cosmetic Functional Ingredients Product Features and Attributes
11.19.4 Syensqo Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.19.5 Syensqo Recent Developments
11.20 CLR Berlin
11.20.1 CLR Berlin Corporation Information
11.20.2 CLR Berlin Business Overview
11.20.3 CLR Berlin Cosmetic Functional Ingredients Product Features and Attributes
11.20.4 CLR Berlin Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.20.5 CLR Berlin Recent Developments
11.21 Active Concepts
11.21.1 Active Concepts Corporation Information
11.21.2 Active Concepts Business Overview
11.21.3 Active Concepts Cosmetic Functional Ingredients Product Features and Attributes
11.21.4 Active Concepts Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.21.5 Active Concepts Recent Developments
11.22 Expanscience
11.22.1 Expanscience Corporation Information
11.22.2 Expanscience Business Overview
11.22.3 Expanscience Cosmetic Functional Ingredients Product Features and Attributes
11.22.4 Expanscience Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.22.5 Expanscience Recent Developments
11.23 Lipoid Kosmetik
11.23.1 Lipoid Kosmetik Corporation Information
11.23.2 Lipoid Kosmetik Business Overview
11.23.3 Lipoid Kosmetik Cosmetic Functional Ingredients Product Features and Attributes
11.23.4 Lipoid Kosmetik Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.23.5 Lipoid Kosmetik Recent Developments
11.24 Vytrus Biotech
11.24.1 Vytrus Biotech Corporation Information
11.24.2 Vytrus Biotech Business Overview
11.24.3 Vytrus Biotech Cosmetic Functional Ingredients Product Features and Attributes
11.24.4 Vytrus Biotech Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.24.5 Vytrus Biotech Recent Developments
11.25 Bloomage Biotech
11.25.1 Bloomage Biotech Corporation Information
11.25.2 Bloomage Biotech Business Overview
11.25.3 Bloomage Biotech Cosmetic Functional Ingredients Product Features and Attributes
11.25.4 Bloomage Biotech Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.25.5 Bloomage Biotech Recent Developments
11.26 JAKA Biotech
11.26.1 JAKA Biotech Corporation Information
11.26.2 JAKA Biotech Business Overview
11.26.3 JAKA Biotech Cosmetic Functional Ingredients Product Features and Attributes
11.26.4 JAKA Biotech Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.26.5 JAKA Biotech Recent Developments
11.27 Shandong Freda Biotechnology
11.27.1 Shandong Freda Biotechnology Corporation Information
11.27.2 Shandong Freda Biotechnology Business Overview
11.27.3 Shandong Freda Biotechnology Cosmetic Functional Ingredients Product Features and Attributes
11.27.4 Shandong Freda Biotechnology Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.27.5 Shandong Freda Biotechnology Recent Developments
11.28 Winkey Technology
11.28.1 Winkey Technology Corporation Information
11.28.2 Winkey Technology Business Overview
11.28.3 Winkey Technology Cosmetic Functional Ingredients Product Features and Attributes
11.28.4 Winkey Technology Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.28.5 Winkey Technology Recent Developments
11.29 Spec-Chem Industry
11.29.1 Spec-Chem Industry Corporation Information
11.29.2 Spec-Chem Industry Business Overview
11.29.3 Spec-Chem Industry Cosmetic Functional Ingredients Product Features and Attributes
11.29.4 Spec-Chem Industry Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.29.5 Spec-Chem Industry Recent Developments
11.30 SIYOMICRO
11.30.1 SIYOMICRO Corporation Information
11.30.2 SIYOMICRO Business Overview
11.30.3 SIYOMICRO Cosmetic Functional Ingredients Product Features and Attributes
11.30.4 SIYOMICRO Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.30.5 SIYOMICRO Recent Developments
11.31 DX Chemical
11.31.1 DX Chemical Corporation Information
11.31.2 DX Chemical Business Overview
11.31.3 DX Chemical Cosmetic Functional Ingredients Product Features and Attributes
11.31.4 DX Chemical Cosmetic Functional Ingredients Revenue and Gross Margin (2021-2026)
11.31.5 DX Chemical Recent Developments
12 Cosmetic Functional Ingredients Value Chain and Ecosystem Analysis
12.1 Cosmetic Functional Ingredients Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Cosmetic Functional Ingredients Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Cosmetic Functional Ingredients Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Cosmetic Functional Ingredients Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Cosmetic Functional Ingredients Market Size Growth Rate by Ingredient Origin, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Cosmetic Functional Ingredients Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Cosmetic Functional Ingredients Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Cosmetic Functional Ingredients Revenue by Region (US$ Million), 2021-2026
Table 6. Global Cosmetic Functional Ingredients Revenue by Region (US$ Million), 2027-2032
Table 7. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 8. Global Cosmetic Functional Ingredients Revenue by Players (US$ Million), 2021-2026
Table 9. Global Cosmetic Functional Ingredients Revenue-Based Market Share by Players (2021-2026)
Table 10. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 11. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on Cosmetic Functional Ingredients Revenue, 2025
Table 12. Global Cosmetic Functional Ingredients Average Gross Margin (%) by Player (2021 vs 2025)
Table 13. Global Cosmetic Functional Ingredients Companies Headquarters
Table 14. Global Cosmetic Functional Ingredients Market Concentration Ratio (CR5)
Table 15. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 16. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 17. Global Cosmetic Functional Ingredients Revenue by Type (US$ Million), 2021-2026
Table 18. Global Cosmetic Functional Ingredients Revenue by Type (US$ Million), 2027-2032
Table 19. Global Cosmetic Functional Ingredients Revenue by Ingredient Origin (US$ Million), 2021-2026
Table 20. Global Cosmetic Functional Ingredients Revenue by Ingredient Origin (US$ Million), 2027-2032
Table 21. Key Product Attributes and Differentiation
Table 22. Global Cosmetic Functional Ingredients Revenue by Application (US$ Million), 2021-2026
Table 23. Global Cosmetic Functional Ingredients Revenue by Application (US$ Million), 2027-2032
Table 24. Cosmetic Functional Ingredients High-Growth Sectors Demand CAGR (2026-2032)
Table 25. Top Customers by Region
Table 26. Top Customers by Application
Table 27. North America Cosmetic Functional Ingredients Growth Accelerators and Market Barriers
Table 28. North America Cosmetic Functional Ingredients Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 29. Europe Cosmetic Functional Ingredients Growth Accelerators and Market Barriers
Table 30. Europe Cosmetic Functional Ingredients Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Asia-Pacific Cosmetic Functional Ingredients Growth Accelerators and Market Barriers
Table 32. Asia-Pacific Cosmetic Functional Ingredients Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Central and South America Cosmetic Functional Ingredients Investment Opportunities and Key Challenges
Table 34. Central and South America Cosmetic Functional Ingredients Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 35. Middle East and Africa Cosmetic Functional Ingredients Investment Opportunities and Key Challenges
Table 36. Middle East and Africa Cosmetic Functional Ingredients Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 37. Croda Corporation Information
Table 38. Croda Description and Major Businesses
Table 39. Croda Product Features and Attributes
Table 40. Croda Revenue (US$ Million) and Gross Margin (2021-2026)
Table 41. Croda Revenue Proportion by Product in 2025
Table 42. Croda Revenue Proportion by Application in 2025
Table 43. Croda Revenue Proportion by Geographic Area in 2025
Table 44. Croda Cosmetic Functional Ingredients SWOT Analysis
Table 45. Croda Recent Developments
Table 46. Givaudan Corporation Information
Table 47. Givaudan Description and Major Businesses
Table 48. Givaudan Product Features and Attributes
Table 49. Givaudan Revenue (US$ Million) and Gross Margin (2021-2026)
Table 50. Givaudan Revenue Proportion by Product in 2025
Table 51. Givaudan Revenue Proportion by Application in 2025
Table 52. Givaudan Revenue Proportion by Geographic Area in 2025
Table 53. Givaudan Cosmetic Functional Ingredients SWOT Analysis
Table 54. Givaudan Recent Developments
Table 55. Symrise Corporation Information
Table 56. Symrise Description and Major Businesses
Table 57. Symrise Product Features and Attributes
Table 58. Symrise Revenue (US$ Million) and Gross Margin (2021-2026)
Table 59. Symrise Revenue Proportion by Product in 2025
Table 60. Symrise Revenue Proportion by Application in 2025
Table 61. Symrise Revenue Proportion by Geographic Area in 2025
Table 62. Symrise Cosmetic Functional Ingredients SWOT Analysis
Table 63. Symrise Recent Developments
Table 64. dsm-firmenich Corporation Information
Table 65. dsm-firmenich Description and Major Businesses
Table 66. dsm-firmenich Product Features and Attributes
Table 67. dsm-firmenich Revenue (US$ Million) and Gross Margin (2021-2026)
Table 68. dsm-firmenich Revenue Proportion by Product in 2025
Table 69. dsm-firmenich Revenue Proportion by Application in 2025
Table 70. dsm-firmenich Revenue Proportion by Geographic Area in 2025
Table 71. dsm-firmenich Cosmetic Functional Ingredients SWOT Analysis
Table 72. dsm-firmenich Recent Developments
Table 73. BASF Corporation Information
Table 74. BASF Description and Major Businesses
Table 75. BASF Product Features and Attributes
Table 76. BASF Revenue (US$ Million) and Gross Margin (2021-2026)
Table 77. BASF Revenue Proportion by Product in 2025
Table 78. BASF Revenue Proportion by Application in 2025
Table 79. BASF Revenue Proportion by Geographic Area in 2025
Table 80. BASF Cosmetic Functional Ingredients SWOT Analysis
Table 81. BASF Recent Developments
Table 82. Clariant Corporation Information
Table 83. Clariant Description and Major Businesses
Table 84. Clariant Product Features and Attributes
Table 85. Clariant Revenue (US$ Million) and Gross Margin (2021-2026)
Table 86. Clariant Recent Developments
Table 87. Solabia Corporation Information
Table 88. Solabia Description and Major Businesses
Table 89. Solabia Product Features and Attributes
Table 90. Solabia Revenue (US$ Million) and Gross Margin (2021-2026)
Table 91. Solabia Recent Developments
Table 92. Evonik Corporation Information
Table 93. Evonik Description and Major Businesses
Table 94. Evonik Product Features and Attributes
Table 95. Evonik Revenue (US$ Million) and Gross Margin (2021-2026)
Table 96. Evonik Recent Developments
Table 97. Seppic Corporation Information
Table 98. Seppic Description and Major Businesses
Table 99. Seppic Product Features and Attributes
Table 100. Seppic Revenue (US$ Million) and Gross Margin (2021-2026)
Table 101. Seppic Recent Developments
Table 102. Ashland Corporation Information
Table 103. Ashland Description and Major Businesses
Table 104. Ashland Product Features and Attributes
Table 105. Ashland Revenue (US$ Million) and Gross Margin (2021-2026)
Table 106. Ashland Recent Developments
Table 107. SILAB Corporation Information
Table 108. SILAB Description and Major Businesses
Table 109. SILAB Product Features and Attributes
Table 110. SILAB Revenue (US$ Million) and Gross Margin (2021-2026)
Table 111. SILAB Recent Developments
Table 112. Lubrizol Corporation Information
Table 113. Lubrizol Description and Major Businesses
Table 114. Lubrizol Product Features and Attributes
Table 115. Lubrizol Revenue (US$ Million) and Gross Margin (2021-2026)
Table 116. Lubrizol Recent Developments
Table 117. Ichimaru Pharcos Corporation Information
Table 118. Ichimaru Pharcos Description and Major Businesses
Table 119. Ichimaru Pharcos Product Features and Attributes
Table 120. Ichimaru Pharcos Revenue (US$ Million) and Gross Margin (2021-2026)
Table 121. Ichimaru Pharcos Recent Developments
Table 122. Greentech Corporation Information
Table 123. Greentech Description and Major Businesses
Table 124. Greentech Product Features and Attributes
Table 125. Greentech Revenue (US$ Million) and Gross Margin (2021-2026)
Table 126. Greentech Recent Developments
Table 127. Gattefossé Corporation Information
Table 128. Gattefossé Description and Major Businesses
Table 129. Gattefossé Product Features and Attributes
Table 130. Gattefossé Revenue (US$ Million) and Gross Margin (2021-2026)
Table 131. Gattefossé Recent Developments
Table 132. Provital Corporation Information
Table 133. Provital Description and Major Businesses
Table 134. Provital Product Features and Attributes
Table 135. Provital Revenue (US$ Million) and Gross Margin (2021-2026)
Table 136. Provital Recent Developments
Table 137. LipoTrue Corporation Information
Table 138. LipoTrue Description and Major Businesses
Table 139. LipoTrue Product Features and Attributes
Table 140. LipoTrue Revenue (US$ Million) and Gross Margin (2021-2026)
Table 141. LipoTrue Recent Developments
Table 142. IFF Corporation Information
Table 143. IFF Description and Major Businesses
Table 144. IFF Product Features and Attributes
Table 145. IFF Revenue (US$ Million) and Gross Margin (2021-2026)
Table 146. IFF Recent Developments
Table 147. Syensqo Corporation Information
Table 148. Syensqo Description and Major Businesses
Table 149. Syensqo Product Features and Attributes
Table 150. Syensqo Revenue (US$ Million) and Gross Margin (2021-2026)
Table 151. Syensqo Recent Developments
Table 152. CLR Berlin Corporation Information
Table 153. CLR Berlin Description and Major Businesses
Table 154. CLR Berlin Product Features and Attributes
Table 155. CLR Berlin Revenue (US$ Million) and Gross Margin (2021-2026)
Table 156. CLR Berlin Recent Developments
Table 157. Active Concepts Corporation Information
Table 158. Active Concepts Description and Major Businesses
Table 159. Active Concepts Product Features and Attributes
Table 160. Active Concepts Revenue (US$ Million) and Gross Margin (2021-2026)
Table 161. Active Concepts Recent Developments
Table 162. Expanscience Corporation Information
Table 163. Expanscience Description and Major Businesses
Table 164. Expanscience Product Features and Attributes
Table 165. Expanscience Revenue (US$ Million) and Gross Margin (2021-2026)
Table 166. Expanscience Recent Developments
Table 167. Lipoid Kosmetik Corporation Information
Table 168. Lipoid Kosmetik Description and Major Businesses
Table 169. Lipoid Kosmetik Product Features and Attributes
Table 170. Lipoid Kosmetik Revenue (US$ Million) and Gross Margin (2021-2026)
Table 171. Lipoid Kosmetik Recent Developments
Table 172. Vytrus Biotech Corporation Information
Table 173. Vytrus Biotech Description and Major Businesses
Table 174. Vytrus Biotech Product Features and Attributes
Table 175. Vytrus Biotech Revenue (US$ Million) and Gross Margin (2021-2026)
Table 176. Vytrus Biotech Recent Developments
Table 177. Bloomage Biotech Corporation Information
Table 178. Bloomage Biotech Description and Major Businesses
Table 179. Bloomage Biotech Product Features and Attributes
Table 180. Bloomage Biotech Revenue (US$ Million) and Gross Margin (2021-2026)
Table 181. Bloomage Biotech Recent Developments
Table 182. JAKA Biotech Corporation Information
Table 183. JAKA Biotech Description and Major Businesses
Table 184. JAKA Biotech Product Features and Attributes
Table 185. JAKA Biotech Revenue (US$ Million) and Gross Margin (2021-2026)
Table 186. JAKA Biotech Recent Developments
Table 187. Shandong Freda Biotechnology Corporation Information
Table 188. Shandong Freda Biotechnology Description and Major Businesses
Table 189. Shandong Freda Biotechnology Product Features and Attributes
Table 190. Shandong Freda Biotechnology Revenue (US$ Million) and Gross Margin (2021-2026)
Table 191. Shandong Freda Biotechnology Recent Developments
Table 192. Winkey Technology Corporation Information
Table 193. Winkey Technology Description and Major Businesses
Table 194. Winkey Technology Product Features and Attributes
Table 195. Winkey Technology Revenue (US$ Million) and Gross Margin (2021-2026)
Table 196. Winkey Technology Recent Developments
Table 197. Spec-Chem Industry Corporation Information
Table 198. Spec-Chem Industry Description and Major Businesses
Table 199. Spec-Chem Industry Product Features and Attributes
Table 200. Spec-Chem Industry Revenue (US$ Million) and Gross Margin (2021-2026)
Table 201. Spec-Chem Industry Recent Developments
Table 202. SIYOMICRO Corporation Information
Table 203. SIYOMICRO Description and Major Businesses
Table 204. SIYOMICRO Product Features and Attributes
Table 205. SIYOMICRO Revenue (US$ Million) and Gross Margin (2021-2026)
Table 206. SIYOMICRO Recent Developments
Table 207. DX Chemical Corporation Information
Table 208. DX Chemical Description and Major Businesses
Table 209. DX Chemical Product Features and Attributes
Table 210. DX Chemical Revenue (US$ Million) and Gross Margin (2021-2026)
Table 211. DX Chemical Recent Developments
Table 212. Technologies, Platforms and Infrastructure
Table 213. Distributors List
Table 214. Market Trends and Market Evolution
Table 215. Market Drivers and Opportunities
Table 216. Market Challenges, Risks, and Restraints
Table 217. Research Programs/Design for This Report
Table 218. Key Data Information from Secondary Sources
Table 219. Key Data Information from Primary Sources


List of Figures
Figure 1. Global Cosmetic Functional Ingredients Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Botanical Actives Product Picture
Figure 3. Peptides & Proteins Product Picture
Figure 4. Polysaccharides Product Picture
Figure 5. Lipids & Ceramides Product Picture
Figure 6. Others Product Picture
Figure 7. Global Cosmetic Functional Ingredients Market Size Growth Rate by Ingredient Origin, 2021 vs 2025 vs 2032 (US$ Million)
Figure 8. Plant-Derived Product Picture
Figure 9. Marine-Derived Product Picture
Figure 10. Fermentation-Derived Product Picture
Figure 11. Others Product Picture
Figure 12. Global Cosmetic Functional Ingredients Market Size Growth Rate , 2021 vs 2025 vs 2032 (US$ Million)
Figure 13. Global Cosmetic Functional Ingredients Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 14. Facial Skin Care
Figure 15. Hair & Scalp Care
Figure 16. Body Care
Figure 17. Sun & After-Sun Care
Figure 18. Others
Figure 19. Cosmetic Functional Ingredients Report Years Considered
Figure 20. Global Cosmetic Functional Ingredients Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 21. Global Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 22. Global Cosmetic Functional Ingredients Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 23. Global Cosmetic Functional Ingredients Revenue-Based Market Share by Region (2021-2032)
Figure 24. Global Cosmetic Functional Ingredients Revenue-Based Market Share Ranking (2025)
Figure 25. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 26. Botanical Actives Revenue-Based Market Share by Player in 2025
Figure 27. Peptides & Proteins Revenue-Based Market Share by Player in 2025
Figure 28. Polysaccharides Revenue-Based Market Share by Player in 2025
Figure 29. Lipids & Ceramides Revenue-Based Market Share by Player in 2025
Figure 30. Others Revenue-Based Market Share by Player in 2025
Figure 31. Global Cosmetic Functional Ingredients Revenue-Based Market Share by Type (2021-2032)
Figure 32. Global Cosmetic Functional Ingredients Revenue-Based Market Share by Ingredient Origin (2021-2032)
Figure 33. Global Cosmetic Functional Ingredients Revenue-Based Market Share by Application (2021-2032)
Figure 34. North America Cosmetic Functional Ingredients Revenue YoY (US$ Million), 2021-2032
Figure 35. North America Top 5 Players Cosmetic Functional Ingredients Revenue (US$ Million) in 2025
Figure 36. North America Cosmetic Functional Ingredients Revenue (US$ Million) by Application (2021-2032)
Figure 37. US Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 38. Canada Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 39. Mexico Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 40. Europe Cosmetic Functional Ingredients Revenue YoY (US$ Million), 2021-2032
Figure 41. Europe Top 5 Players Cosmetic Functional Ingredients Revenue (US$ Million) in 2025
Figure 42. Europe Cosmetic Functional Ingredients Revenue (US$ Million) by Application (2021-2032)
Figure 43. Germany Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 44. France Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 45. U.K. Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 46. Italy Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 47. Russia Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 48. Asia-Pacific Cosmetic Functional Ingredients Revenue YoY (US$ Million), 2021-2032
Figure 49. Asia-Pacific Top 8 Players Cosmetic Functional Ingredients Revenue (US$ Million) in 2025
Figure 50. Asia-Pacific Cosmetic Functional Ingredients Revenue (US$ Million) by Application (2021-2032)
Figure 51. Indonesia Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 52. Japan Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 53. South Korea Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 54. Australia Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 55. India Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 56. Indonesia Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 57. Vietnam Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 58. Malaysia Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 59. Philippines Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 60. Singapore Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 61. Central and South America Cosmetic Functional Ingredients Revenue YoY (US$ Million), 2021-2032
Figure 62. Central and South America Top 5 Players Cosmetic Functional Ingredients Revenue (US$ Million) in 2025
Figure 63. Central and South America Cosmetic Functional Ingredients Revenue (US$ Million) by Application (2021-2032)
Figure 64. Brazil Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 65. Argentina Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 66. Middle East and Africa Cosmetic Functional Ingredients Revenue YoY (US$ Million), 2021-2032
Figure 67. Middle East and Africa Top 5 Players Cosmetic Functional Ingredients Revenue (US$ Million) in 2025
Figure 68. Middle East and Africa Cosmetic Functional Ingredients Revenue (US$ Million) by Application (2021-2032)
Figure 69. GCC Countries Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 70. Israel Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 71. Egypt Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 72. South Africa Cosmetic Functional Ingredients Revenue (US$ Million), 2021-2032
Figure 73. Cosmetic Functional Ingredients Value Chain Mapping
Figure 74. Channels of Distribution (Direct Vs Distribution)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed